ST Pharm · Tue, Oct 27 JONBUR's Squeeze! rule confirmed a downside breakout (SHORT): after weeks of unusually tight trading, the price broke below its range with momentum. Reported reason for the move: Q3 revenue up 19% and operating profit up 6.6% year on year; its own results were released, though the stock fell. −9.2% today · −12.3% this month · −32.6% this year Chart: 5% above its 52-week low · RSI 34 · below its 20- and 200-day averages · volume 2.9× normal · foreign investors net sold ₩4.4B See the short-squeeze levels for every stock with Squeeze Pro: https://jonbur.com/pricing#squeeze
Not financial advice.